抗合成酶综合征新内型独立于抗氨酰基转移RNA合成酶抗体特异性并改善预后分层
该研究回顾性纳入701例抗合成酶综合征(ASS)患者,分析四种抗ARS抗体亚型与临床表现及预后的关联,并采用无监督机器学习进行聚类。结果显示四种抗体亚型在快速进展性间质性肺病(RP-ILD)发生率或预后上无显著差异,而独立于抗体特异性识别出三种内型,其临床特征、预后及转录组特征各异。
要点
- 四种抗ARS抗体亚型间RP-ILD发生率和预后无显著差异。
- 无监督机器学习识别出三种内型:RP-ILD型(23.7%)、DM样型(14.5%)、关节炎型(61.8%)。
- 不同内型具有不同的临床结局和转录组特征。
核心结论
- 抗ARS抗体在将ASS患者分层为RP-ILD和预后更均一的亚组方面无显著意义。
- 独立于抗ARS特异性识别出新的ASS内型,其临床结局和转录组特征不同,为ASS发病机制提供了新见解。
研究设计与样本
- 回顾性纳入701例ASS患者,评估临床表现和预后与四种抗ARS抗体(抗Jo1、抗PL7、抗PL12、抗EJ)的关联。
- 采用无监督机器学习进行独立于抗ARS抗体的患者聚类,并对聚类ASS患者和健康对照进行转录组测序。
主要发现
- 四种不同抗ARS抗体亚型患者在RP-ILD发生率或预后方面无显著差异。
- 内型1(RP-ILD聚类,23.7%)以RP-ILD高发生率和 high mortality rate 为特征。
- 内型2(皮肌炎样聚类,14.5%)对应具有皮肌炎样皮肤和肌肉症状的患者,预后中等。
- 内型3(关节炎聚类,61.8%)以关节炎和技工手为特征,预后良好。
- 转录组测序揭示不同内型具有不同的基因特征和生物学过程。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systemically analyse the heterogeneity in the clinical manifestations and prognoses of patients with antisynthetase syndrome (ASS) and evaluate the transcriptional signatures related to different clinical phenotypes. METHODS: A total of 701 patients with ASS were retrospectively enrolled. The clinical presentation and prognosis were assessed in association with four anti-aminoacyl transfer RNA synthetase (ARS) antibodies: anti-Jo1, anti-PL7, anti-PL12 and anti-EJ. Unsupervised machine learning was performed for patient clustering independent of anti-ARS antibodies. Transcriptome sequencing was conducted in clustered ASS patients and healthy controls. RESULTS: Patients with four different anti-ARS antibody subtypes demonstrated no significant differences in the incidence of rapidly progressive interstitial lung disease (RP-ILD) or prognoses. Unsupervised machine learning, independent of anti-ARS specificity, identified three endotypes with distinct clinical features and outcomes. Endotype 1 (RP-ILD cluster, 23.7%) was characterised by a high incidence of RP-ILD and a high mortality rate. Endotype 2 (dermatomyositis (DM)-like cluster, 14.5%) corresponded to patients with DM-like skin and muscle symptoms with an intermediate prognosis. Endotype 3 (arthritis cluster, 61.8%) was characterised by arthritis and mechanic's hands, with a good prognosis. Transcriptome sequencing revealed that the different endotypes had distinct gene signatures and biological processes. CONCLUSIONS: Anti-ARS antibodies were not significant in stratifying ASS patients into subgroups with greater homogeneity in RP-ILD and prognoses. Novel ASS endotypes were identified independent of anti-ARS specificity and differed in clinical outcomes and transcriptional signatures, providing new insights into the pathogenesis of ASS.
引用
- Wu S, Xiao X, Zhang Y, et al. Novel endotypes of antisynthetase syndrome identified independent of anti-aminoacyl transfer RNA synthetase antibody specificity that improve prognostic stratification. Ann Rheum Dis. 2024. PMID: 38395605. doi:10.1136/ard-2023-225284
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。